Drug Profile
Human papillomavirus vaccine recombinant bivalent - EyeGene
Alternative Names: EG-HPV; HPV VLP vaccine - Eyegene; Human papillomavirus (types 16 and 18) L1 virus-like particle vaccine - EyeGeneLatest Information Update: 28 Mar 2018
Price :
$50
*
At a glance
- Originator EyeGene
- Class Cancer vaccines; Papillomavirus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cervical cancer; Human papillomavirus infections; Penile cancer
Most Recent Events
- 28 Mar 2018 No recent reports of development identified for phase-I development in Cervical-cancer(Prevention, In volunteers) in South Korea (Parenteral, Injection)
- 28 Mar 2018 No recent reports of development identified for phase-I development in Human-papillomavirus-infections(Prevention, In volunteers) in South Korea (Parenteral, Injection)
- 28 Mar 2018 No recent reports of development identified for phase-I development in Penile-cancer(Prevention, In volunteers) in South Korea (Parenteral, Injection)